Skip to main content
Daily Report

Daily Anesthesiology Research Analysis

04/05/2026
3 papers selected
43 analyzed

Analyzed 43 papers and selected 3 impactful papers.

Summary

Analyzed 43 papers and selected 3 impactful articles.

Selected Articles

1. Recovery quality with regional anesthesia and dexmedetomidine sedation versus general anesthesia for ambulatory breast cancer surgery: A randomized trial.

75.5Level IRCT
Breast (Edinburgh, Scotland) · 2026PMID: 41932294

In 96 randomized patients undergoing ambulatory breast-conserving surgery with sentinel node biopsy, regional anesthesia plus dexmedetomidine sedation produced higher QoR-15 scores at 6 hours than general anesthesia, with benefits also at 2 and 24 hours. The regional anesthesia group had lower early pain, less rescue analgesia (27% vs 56%), markedly reduced nausea/vomiting (2% vs 27%), and more stable intraoperative hemodynamics.

Impact: This pragmatic RCT provides patient-centered evidence that regional anesthesia with alpha-2 agonist sedation enhances early recovery and decreases PONV and analgesic needs in ambulatory oncologic surgery.

Clinical Implications: For breast-conserving ambulatory procedures, implementing PECS/intercostal blocks with dexmedetomidine sedation may improve short-term recovery quality, reduce PONV and opioid rescue, and provide steadier hemodynamics compared with general anesthesia.

Key Findings

  • QoR-15 scores at 6 hours were significantly higher with regional anesthesia plus dexmedetomidine (median 142 [136, 146]) vs general anesthesia (132 [127, 135]; p<0.01).
  • Lower pain at 2 hours with reduced rescue analgesia in the regional group (27% vs 56%; p<0.01).
  • Markedly less postoperative nausea/vomiting with regional anesthesia (2% vs 27%; p<0.01) and fewer intra-incision hypotensive episodes.

Methodological Strengths

  • Randomized controlled design with standardized regional and general anesthetic protocols
  • Use of validated patient-centered outcome (QoR-15) at multiple timepoints

Limitations

  • Single-center trial with modest sample size and short (24 h) follow-up
  • Open-label nature inherent to technique differences may introduce performance bias

Future Directions: Larger multicenter RCTs with longer follow-up should assess patient-reported outcomes, longer-term pain, opioid consumption, cost-effectiveness, and oncologic workflow impacts.

BACKGROUND: Advances in regional anesthesia techniques and the widespread use of ultrasound guidance have enabled safe and effective anesthesia for ambulatory breast cancer surgery, eliminating the general anesthesia-associated systemic effects. We therefore compared regional anesthesia with dexmedetomidine sedation to general anesthesia on the 15-item postoperative quality of recovery (QoR-15). METHODS: Ninety-six patients scheduled for breast-conserving surgery and sentinel lymph node biopsy were randomly assigned to regional anesthesia with sedation or general anesthesia. In patients assigned to regional anesthesia, a 0.3% ropivacaine solution was used for pectoral and intercostal nerve blocks, followed by a dexmedetomidine infusion. In other patients, standardized general anesthesia was maintained with a laryngeal mask airway. The primary outcome was the QoR-15 score 6 h after surgery. Secondary outcomes included QoR-15 scores at 2 and 24 h; pain scores obtained using the numerical rating scale (NRS) at 2, 6, and 24 h; and the incidence of postoperative complications.

2. Comparison of neck-extended and modified ramped positions for locating the cricothyroid membrane in obese anesthetized patients.

72.5Level IRCT
The American journal of emergency medicine · 2026PMID: 41932263

In 112 anesthetized obese female patients, a modified ramped position significantly increased accurate cricothyroid membrane identification compared with neck extension (77% vs 48%; p=0.002) without prolonging localization time and with lower perceived difficulty.

Impact: Accurate cricothyroid membrane localization is pivotal for emergency front-of-neck airway access. This randomized comparison provides actionable, patient-positioning guidance in a high-risk obese population.

Clinical Implications: Adopting the modified ramped position may improve first-pass accuracy of cricothyroid membrane identification in obese anesthetized women, potentially reducing failed or delayed emergency cricothyrotomy.

Key Findings

  • Accurate identification success rate was higher with the modified ramped position vs neck-extended (77% vs 48%; P=0.002).
  • Time to locate the membrane center was similar between positions (46.0 s vs 41.0 s; P=0.562).
  • Anesthesiologists reported lower palpation difficulty in the modified ramped position (P=0.019).

Methodological Strengths

  • Randomized comparative design in a clinically relevant high-risk population
  • Standardized palpation technique (laryngeal handshake) and predefined outcomes

Limitations

  • Restricted to obese female patients; generalizability to males and non-obese populations is uncertain
  • Did not assess downstream procedural success (e.g., actual cricothyrotomy performance) or use ultrasound confirmation

Future Directions: Evaluate whether the modified ramped position improves time-to-secure front-of-neck airway and success rates in simulated and real emergency settings, including diverse BMI and sex groups with ultrasound confirmation.

OBJECTIVE: Precise localization of the cricothyroid membrane in obese women is challenging. This randomized comparative study aimed to evaluate the neck-extended position versus the modified ramped position in terms of success rate, time required, and perceived difficulty in identifying the cricothyroid membrane in anesthetized obese female patients. METHODS: After the induction of anesthesia in 112 obese female patients, the cricothyroid membrane was identified using the laryngeal handshake technique in the neck-extended or modified ramped position. In the neck-extended position, a pillow was placed beneath the shoulders in the supine position. The modified ramped position was achieved by combining a ramped position with full head extension using a specialized pillow. The success rate of accurate identification of the cricothyroid membrane, time required to locate the cricothyroid membrane center, and the subjective difficulty of cricothyroid membrane palpation were recorded. RESULTS: The success rate of accurate identification of the cricothyroid membrane was significantly higher in the modified ramped position than in the neck-extended position (77% vs. 48%, respectively; P = 0.002). The time required for localization of the cricothyroid membrane center did not differ between the neck-extended and modified ramped positions (46.0 [23.2] s vs. 41.0 (15.0) s, respectively; P = 0.562). The subjective difficulty of cricothyroid membrane palpation as perceived by anesthesiologists was significantly lower in the modified ramped position than in the neck-extended position (P = 0.019). CONCLUSION: The modified ramped position facilitated accurate identification of the cricothyroid membrane and reduced the difficulty of cricothyroid membrane palpation in anesthetized obese female patients compared with the neck-extended position.

3. Standardization of In-Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development.

71.5Level IVSystematic methodology consensus/guideline
Interdisciplinary cardiovascular and thoracic surgery · 2026PMID: 41933908

An international multidisciplinary group proposes standardized in‑vitro testing and reporting criteria for ECLS components and devices to improve reproducibility, comparability, and translation of early-stage R&D findings into clinical practice.

Impact: Methodological standardization can reduce waste, enhance cross-study comparability, and accelerate safer ECLS innovation—key for anesthesiologists and intensivists deploying ECMO/ECLS.

Clinical Implications: Adopting unified in‑vitro protocols and reporting standards can improve device selection and procurement, inform regulatory submissions, and ultimately enhance patient safety by aligning preclinical performance with clinical needs.

Key Findings

  • Identifies lack of standardized in‑vitro evaluation as a barrier to comparing ECLS device performance and hemocompatibility.
  • Recommends clear, internationally aligned protocols and reporting criteria to ensure methodological consistency and reproducibility.
  • Anticipates improved data interpretation and decision-making for ECLS development and clinical application through a unified framework.

Methodological Strengths

  • International, multidisciplinary expert consensus spanning engineering, clinical, and industry stakeholders
  • Alignment with international norms and emphasis on reproducibility and transparent reporting

Limitations

  • Consensus document without empirical validation of proposed protocols
  • Implementation may vary across laboratories and device types until adoption is widespread

Future Directions: Conduct inter-laboratory ring trials to validate protocols, link in‑vitro metrics to clinical outcomes, and iteratively refine standards for diverse ECLS components.

Extracorporeal life support (ECLS) technology has witnessed remarkable advancements during the last decades. However, further research and development of devices are required to increase, for example, performance-efficiency, hemocompatibility, and long-term stability. All novel devices, even in early research stages, must undergo rigorous testing and evaluation. Yet, these early evaluations are often conducted under nonstandardized conditions, resulting in data difficult to compare, interpret, or translate into clinical practice. Establishing well-defined, standardized in-vitro testing protocols for all ECLS components and devices would represent a major step forward. Such protocols would improve methodological consistency and ensure reproducibility across research groups. This document, developed by an international group of ECLS experts from all disciplines in which such components are designed, developed, and applied, provides clear recommendations and standardized criteria for device testing according to international norms. Adoption of these criteria including the ways of reporting results will foster a unified approach among scientists, engineers, clinicians, and the medical device industry. Ultimately, this common framework will facilitate data interpretation, improve comparability of study results between different groups, making the review of studies more straightforward, as not every aspect of testing requires additional review and discussion, certainly favoring decision-making in the development and application of ECLS technologies.